CAS: 1374248-77-7 - Ubrogepant
Formel:C29H26F3N5O3
InChl:InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1
InChI Key:InChIKey=DDOOFTLHJSMHLN-ZQHRPCGSSA-N
SMILES:O=C(NC1C(=O)N(CC(F)(F)F)C(C)C(C=2C=CC=CC2)C1)C3=CN=C4C(=C3)CC5(C(=O)NC6=NC=CC=C65)C4
- Synonyme:
- Ubrelvy
- Ubrogepant
- Spiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1′,2′,5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxo-, (3′S)-
- (3′S)-1′,2′,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide
- MK 1602
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Ubrogepant-d5 REF: 4Z-U-018002CAS: 1374248-77-7 | - - - | Nachfragen | Di 07 Jan 25 | |
Ubrogepant REF: 4Z-U-018001CAS: 1374248-77-7 | - - - | Nachfragen | Di 07 Jan 25 | |
Ubrogepant REF: 3D-FU165699CAS: 1374248-77-7 | Min. 95% | 1.148,00 €~3.507,00 € | Mo 03 Mär 25 | |
Ubrogepant REF: TM-T17194CAS: 1374248-77-7 | 99.79% | 150,00 €~1.643,00 € | Mo 10 Mär 25 |
Ref: 4Z-U-018002
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Ref: 4Z-U-018001
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Ubrogepant
Ref: 3D-FU165699
1mg | 1.148,00 € | ||
2mg | 1.531,00 € | ||
5mg | 2.104,00 € | ||
10mg | 3.507,00 € |
Ubrogepant
Ref: TM-T17194
1mg | 150,00 € | ||
5mg | 369,00 € | ||
10mg | 583,00 € | ||
25mg | 914,00 € | ||
50mg | 1.198,00 € | ||
100mg | 1.643,00 € | ||
1mL*10mM (DMSO) | 484,00 € |